NeuroOne Medical Technologies (NMTC) Institutional Ownership $0.71 -0.07 (-8.96%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NeuroOne Medical Technologies (NASDAQ:NMTC)CurrentInstitutional OwnershipPercentage16.07%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$81.68KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$198.36K Get NMTC Insider Trade Alerts Want to know when executives and insiders are buying or selling NeuroOne Medical Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NMTC Institutional Buying and Selling by Quarter Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. NeuroOne Medical Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC283,855$281K0.0%+9.6%0.921% 11/15/2024 XTX Topco Ltd26,408$26K0.0%N/A0.086% 8/20/2024 Nantahala Capital Management LLC950,962$761K0.0%-20.7%3.416% 1/11/2024Wealth Alliance Advisory Group LLC19,500$31K0.0%N/A0.081% 11/2/2023 Perkins Capital Management Inc.150,000$134K0.1%N/A0.627% 4/28/2023 SG Americas Securities LLC57,219$92K0.0%N/A0.350% 4/20/2023 Princeton Global Asset Management LLC16,833$27K0.0%N/A0.103% 4/13/2023 Drive Wealth Management LLC34,380$55K0.0%-46.5%0.210% 2/9/2023 Mayo Clinic181,754$218K0.1%N/A1.118% 1/26/2023 Mayo Clinic181,754$218K1.1%N/A1.119% 11/16/2022 Drive Wealth Management LLC66,667$113K0.1%N/A0.411% 8/9/2022Kingsbury Capital Investment Advisors LLC53,403$44K0.1%N/A0.330% 2/15/2022 Stonepine Capital Management LLC498,354$967K0.4%N/A3.079% 2/10/2022 Bleichroeder LP375,000$728K0.1%N/A2.317% 2/10/2022 AIGH Capital Management LLC475,000$921K0.3%N/A2.934% 2/1/2022Eidelman Virant Capital75,000$146K0.1%N/A0.463% 10/15/2021Intersect Capital LLC50,000$198K0.0%N/A0.417% 8/17/2021 Baker Avenue Asset Management LP179,370$1.19M0.1%N/A1.500% 8/16/2021Premier Asset Management LLC50,000$332K0.0%N/A0.418% (Data available from 1/1/2016 forward) NMTC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NMTC shares? During the previous two years, 9 institutional investors and hedge funds held shares of NeuroOne Medical Technologies. The most heavily invested institutionals were Nantahala Capital Management LLC ($761K), Geode Capital Management LLC ($281K), Mayo Clinic ($218K), Perkins Capital Management Inc. ($134K), SG Americas Securities LLC ($92K), Drive Wealth Management LLC ($55K), and Wealth Alliance Advisory Group LLC ($31K).Learn more on NMTC's institutional investors. What percentage of NeuroOne Medical Technologies stock is owned by institutional investors? 16.07% of NeuroOne Medical Technologies stock is owned by institutional investors. Learn more on NMTC's institutional investor holdings. Which institutional investors have been buying NeuroOne Medical Technologies stock? The following institutional investors have purchased NeuroOne Medical Technologies stock in the last 24 months: Mayo Clinic ($363.51K), Perkins Capital Management Inc. ($150K), SG Americas Securities LLC ($57.22K), XTX Topco Ltd ($26.41K), Geode Capital Management LLC ($24.97K), Wealth Alliance Advisory Group LLC ($19.50K), and Princeton Global Asset Management LLC ($16.83K). How much institutional buying is happening at NeuroOne Medical Technologies? Institutional investors have bought a total of 658,440 shares in the last 24 months. This purchase volume represents approximately $770.67K in transactions. Which NeuroOne Medical Technologies major shareholders have been selling company stock? The following institutional investors have sold NeuroOne Medical Technologies stock in the last 24 months: Nantahala Capital Management LLC ($247.95K), and Drive Wealth Management LLC ($29.82K). How much institutional selling is happening at NeuroOne Medical Technologies? Institutional investors have sold a total of 277,773 shares in the last 24 months. This volume of shares sold represents approximately $246.38K in transactions. Related Companies LNSR Institutional Ownership MGRM Institutional Ownership TELA Institutional Ownership MODD Institutional Ownership ICAD Institutional Ownership NVNO Institutional Ownership NSPR Institutional Ownership LUCD Institutional Ownership CTSO Institutional Ownership APYX Institutional Ownership This page (NASDAQ:NMTC) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.